Osumili, B.* ; Sapin, H.* ; Yang, Z.* ; Ranta, K.* ; Paik, J.S.* ; Blüher, M.
Efficacy and safety of tirzepatide compared with GLP-1 RAs in patients with type 2 diabetes treated with basal insulin: A network meta-analysis.
Diabetes Ther. 16, 1279-1311 (2025)
Gutgesell, R.M. ; Nogueiras, R.* ; Tschöp, M.H. ; Müller, T.D.
Dual and triple incretin-based co-agonists: Novel therapeutics for obesity and diabetes.
Diabetes Ther. 15, 1069-1084 (2024)
Matthews, D.* ; Del Prato, S.* ; Mohan, V.* ; Mathieu, C.* ; Vencio, S.* ; Chan, J.C.N.* ; Stumvoll, M. ; Paldánius, P.M.*
Insights from VERIFY: Early combination therapy provides better glycaemic durability than a stepwise approach in newly diagnosed type 2 diabetes.
Diabetes Ther. 11, 2465-2476 (2020)
Modafferi, S.* ; Ries, M.* ; Calabrese, V.* ; Schmitt, C.P.* ; Nawroth, P.P. ; Kopf, S.* ; Peters, V.*
Clinical trials on diabetic nephropathy: A cross-sectional analysis.
Diabetes Ther. 10, 229-243 (2019)